Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Journal of Breast Disease(Electronic Edition) ›› 2008, Vol. 02 ›› Issue (01): 40-43. doi: 10.3877/cma.j.issn.1674-0807.2008.01.012

• Experimental Research • Previous Articles     Next Articles

Research of antisense rescue of mutant p53 gene in vitro

Yu-lan SUN1, Ya-hong WANG1, Yuanyuan ZHANG1, Shao-feng XU1, Li FU,1()   

  1. 1.Department of Breast Pathology and Research,Cancer Hospital,Tianjin Medical University;Key Laboratory of Breast Cancer Prevention and Therapy, Ministry of Education, Tianjin 300060,China
  • Received:2007-12-03 Online:2008-02-01 Published:2024-12-04
  • Contact: Li FU

Abstract:

Objective

To investigate the inhibitive efficacy of individual antisense RNA in combination with wild-type p53 gene(wt-p53) in vitro on the proliferation of breast cancer cells and explore its possible gene therapeutic implications.

Methods

pC53-SN3 plasmids were transferred into MDA-MB-231 cells and transfected WTp53-231 cells which stably expressed wt-p53 were screened with G418. MDA-MB-231 cells and Wtp53-231 cells were exposed to cationic liposome-ASp53exon8'RNA,and the growth inhibition rate,expression of p53,and induction of apoptosis were measured with MTT method,TUNE method,and immunocytochemistry staining with LSAB method respectively 48 hours later.

Results

When WTp53-231 cell was transfected with ASp53exon8'RNA,the growth inhibition of tumor cells and increase of apoptotic rate were manifested in WTp53-231 cell, furthermore,synergistic effects were observed compared with MDA-MB-231 cell.

Conclusions

ASp53exon8'RNA in combination with wt-p53 gene transfer can synergistically suppress cell growth,which may serve as effective strategy for human cancer treatment.

Key words: Breast neoplasma, Individual antisense RNA, p53 gene, Gene therapy

京ICP 备07035254号-13
Copyright © Chinese Journal of Breast Disease(Electronic Edition), All Rights Reserved.
Tel: 0086-10-51322630 E-mail: jcbd@medmail.com.cn
Powered by Beijing Magtech Co. Ltd